Stem cell therapy

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Jump to: navigation, search

Stem cell therapy, in particular the use of mesenchymal stromal cells (MSCs) is a potential treatment that has been suggested for ME/CFS.[1]

Theory[edit | edit source]

Diagram showing stimulated, suppressed and inhibited effects on immune system.
iDC, immature dendritic cell; IL, interleukin;
HGF, hepatocyte growth factor;
TGF-β, transforming growth factor-β;
PGE-2, prostaglandin E2; IDO, indoleamine-2,3-dioxygenase;
NO, nitric oxide; PD-L1, programmed death-ligand 1;
hMSC, human mesenchymal stem cell;
Treg, T regulatory; Th, T helper cell
CTL, cytotoxic T cell; mDC, mature dendritic cell
PD-1, programmed cell death protein ;1
PMN, polymorphonuclear leukocyte;
NK, Natural killer cell

Evidence[edit | edit source]

Clinical trials of stem cell therapies have not yet been published.[1]

Clinicians[edit | edit source]

Risks and safety[edit | edit source]

Costs and availability[edit | edit source]

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]

β β / Β. Greek letter beta (a symbol used in science), equivalent to "b".

indoleamine (IDO) - any derivatives of an indole (e.g., serotonin, tryptophan) that contain an amine group

indole (IDO) - a signalling molecule produced by bacteria as a result of metabolising tryptophan, found in the intestines

apoptosis a type of cell death in which a cell, in response to a threat, initiates a series of molecular steps that lead to its orderly death. This is one method the body uses to get rid of unneeded or abnormal cells. This form of cell suicide is also called programmed cell death.

The information provided at this site is not intended to diagnose or treat any illness.
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history.